Target intelligence / Profile preview

RNA, U6 small nuclear 239, pseudogene (RNU6-239P)

Target
RNU6-239P
Molecular classification
Non-coding RNA (pseudogene), Small nuclear RNA pseudogene
01

Overview

**RNA, U6 small nuclear 239, pseudogene (RNU6-239P)** is a human gene classified as a pseudogene of the U6 small nuclear RNA gene family[2]. U6 snRNA genes encode non-coding RNAs that are core components of the spliceosome and highly conserved across evolution[1][3]. However, RNU6-239P specifically is a pseudogene, meaning it is a non-functional genomic relic originally derived from a functional U6 snRNA gene. Pseudogenes such as RNU6-239P generally do not produce active RNA or protein products, have no known biological activity, and are not considered valid therapeutic targets. Their presence reflects the proliferation and evolutionary divergence of the U6 snRNA gene family in primate and vertebrate genomes; many copies exist, both functional and pseudogenic, on the human genome[1][2]. There is no evidence linking RNU6-239P to human disease, drug interaction, or use as a biomarker or therapeutic target[2][5]. Its sequence provides evidence for evolutionary mechanisms such as duplication and mutation but otherwise has no direct significance in cell biology or medicine.

Other names
RNU6-239PU6 snRNA pseudogene 239
02

Biological functions

Other (no known active function; pseudogene)
03

Disease associations

Other (no established roles; pseudogene)

Beyond the preview

Go deeper on RNA, U6 small nuclear 239, pseudogene (RNU6-239P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 239, pseudogene (RNU6-239P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call